[Joint release with Wake County Economic Development and the Town of Holly Springs}
Ypsomed, the leading developer and manufacturer of injection systems for the self-administration of liquid medicine, today announced plans to invest $195.4 million in its first North American manufacturing facility.
"Establishing our new production site in the United States marks an important milestone in Ypsomed’s global growth strategy. We have deliberately chosen Holly Springs, a location at the very heart of our industry, close to our customers. The cooperative approach of the local authorities, the excellent infrastructure and the proximity to top-tier universities provide ideal conditions for our future growth. This environment will allow us to attract the skilled workforce we need and to further strengthen our position as a leading supplier of self-injection systems worldwide", said Simon Michel, CEO of Ypsomed.
Headquartered in Burgdorf, Switzerland, Ypsomed operates globally with over 2,000 employees across multiple production sites. The North American manufacturing facility will expand production capacity and global partnerships. Ypsomed’s plans initially call for 62 new jobs, with the intention to grow significantly in the coming years.
“We’re excited that Ypsomed chose Wake County as the location of its first North American manufacturing facility,” said Chair Susan Evans of the Wake County Board of Commissioners. “Not only will the company deliver $195.4 million in investments and create 62 new jobs in our community, but it will also generate medical devices here that will support the health of people with chronic conditions around the world.”
In recent years, Holly Springs has emerged as a preferred location for the life science industry thanks to long-term strategic planning to position the Town as an ideal home for these companies. Global heavyweights including CSL Seqirus, FUJIFILM Biotechnologies, Amgen and Genentech have already made significant investments in the community.
“This announcement brings an expansion in the life science offerings in Holly Springs, diversifying the types of companies located here,” said Town of Holly Springs Mayor Sean Mayefskie. “Everyone knows about the global biotech leaders who call Holly Springs home, and Ypsomed will provide needed supplies to contribute to the creation of life-saving medications these companies will produce right here in Holly Springs.”
With more than 650 life sciences operations in the Triangle alone, all phases of the biopharmaceutical supply chain are represented from research all the way through product development, device manufacturing, fill/finish and delivery. Wake County brings together research, talent and community to scale the industry and move ideas to market.
“The self-injectable market is a quickly evolving and expanding market," said Christopher Chung, CEO of the Economic Development Partnership of North Carolina. "Welcoming a company like Ypsomed into our dynamic life sciences community is a tremendous win for Holly Springs, Wake County, North Carolina, and all the people Ypsomed continues to support through its innovative products.”
Ypsomed has selected THE YIELD Holly Springs, a purpose-built life science campus developed by Crescent Communities. They plan to purchase and customize a new 110,000 square foot manufacturing building to be operational by the end of 2027.
Numerous partners collaborated to make this announcement a reality. Partners on this project include:
- Capital Area Workforce Development Board
- The Economic Development Partnership of North Carolina
- Duke Energy
- The Town of Holly Springs
- Wake County Board of Commissioners
- Wake County Economic Development, a program of the Greater Raleigh Chamber
- Wake Technical Community College
